Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Assets Average (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Assets Average for 12 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 23.94% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 23.94% year-over-year, with the annual reading at $1.2 billion for FY2025, 36.79% up from the prior year.
  • Assets Average for Q4 2025 was $1.3 billion at Madrigal Pharmaceuticals, up from $1.2 billion in the prior quarter.
  • The five-year high for Assets Average was $1.3 billion in Q4 2025, with the low at $187.5 million in Q3 2022.
  • Average Assets Average over 5 years is $606.7 million, with a median of $333.2 million recorded in 2021.
  • The sharpest move saw Assets Average tumbled 40.72% in 2022, then soared 302.1% in 2024.
  • Over 5 years, Assets Average stood at $289.0 million in 2021, then decreased by 9.83% to $260.6 million in 2022, then surged by 68.55% to $439.3 million in 2023, then surged by 140.81% to $1.1 billion in 2024, then grew by 23.94% to $1.3 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.3 billion, $1.2 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.